Welcome
01 / 08Welcome
Valencia Nutrition Ltd. · Investor Gallery

One listed parent, five subsidiaries built for scalable wellness

Valencia Nutrition Ltd. builds wellness businesses inside its subsidiaries, proves their economics, raises growth capital and lists them separately from the parent. This gallery walks you through each one.

Valencia Nutrition Ltd.
02 — About VNL

Wellness inside the formats people already buy

Valencia Nutrition Ltd. (VNL) is a BSE SME listed FMCG conglomerate built to integrate wellness into everyday consumption without changing existing consumption formats and habits.

Anchored in a “Reach-to-Point-of-Consumption” operating philosophy, VNL combines research-driven product development with operational rigour to build scalable, category-relevant businesses across the wellness-oriented FMCG landscape.

VNL is a capital-efficient operating platform, engineered to build businesses of subsidiaries, prove their economics, raise growth capital, and list them separately from the listed parent company.

Reach-to-Point-of-ConsumptionDistribution designed around where the product is actually consumed.
Research-firstProducts developed from consumer and category research.
In-house engineeringMachinery and value-added products developed internally.
03 — The promoter

Mr. Manish Turakhia

The company is promoted by Mr. Manish Turakhia, whose leadership has been instrumental in repositioning VNL for its next phase of growth.

He is a seasoned capital market investor with over four decades of experience in equity research and cross-sector analysis spanning financial services, consumer businesses, and emerging growth industries. At VNL, he developed an in-house engineering group with multiple skillsets to develop cutting-edge machinery and value-added products.

Having spent a significant part of his career evaluating business models, consumer demand patterns, and long-term value creation across Indian markets, he now brings an operator’s lens to VNL, underpinned by a research-first mindset and a practical understanding of building durable consumer brands within India’s price-sensitive, scale-driven ecosystem.

His greatest valuation discovery: companies across the globe that manufacture low-ticket consumer items with a repetitive consumption pattern.

Valencia NutritionPromoter & MD
PHOTO
PLACEHOLDER

Manish Turakhia

Promoter & Managing Director
Valencia Nutrition Limited
manish@valencianutrition.com
+91 98200 34359
A/601, Neelkanth Kingdom, Neelkanth Business Park, Vidyavihar West, Mumbai, Maharashtra 400086, India
04 — The raise

₹1,500 Cr of planned equity across five subsidiaries

From ₹1,500 Cr of planned equity deployment to a projected ₹51,787 Cr 5th-year revenue platform by FY31–32. Switch the chart between equity raise and projected market cap, and hover or tap a bar for that subsidiary’s projections.

Planned equity deployment₹1,500 Cr
Projected 5th-year revenue platform (FY31–32)₹51,787 Cr
Accumulated 5-year surplus retained earnings₹23,952 Cr
Total projected market cap · end of year 5 (post listing)₹1,15,258 CrRising to ₹1,94,835 Cr after a ₹20,000 Cr QIP in FY32–33

Projected figures: forward-looking estimates, not guarantees of future performance. [PLACEHOLDER: legal disclaimer]

Equity fund raise by subsidiary

₹ Cr, FY31–32 projections · total ₹1,500 Cr

05 — The five subsidiaries

Where the capital goes

Each subsidiary has its own listing and QIP pathway. Open one for its investor snapshot, financing stage and business documents.

Hover a business to see its brands and products

06 — Why now

Why a growth investor should be looking now

01

Entry before the value curve

Multiple businesses are being built before their scale is reflected in the parent’s valuation. This is the classic window for a growth investor.

02

Portfolio optionality

Exposure to beverages, healthy snacks, automated retail and nutracare gives the Group several independent routes to scale, each with its own listing and QIP pathway.

03

Manufacturing is the margin lever

Production moving in-house assures consistent quality where scale justifies it, lowering the cost architecture and reinvesting the savings into growth.

07 — Investor documents

Everything from the equity issuance brief

The documents linked in VNL’s CCPS equity issuance brief, viewable here. Open one to read it in place.

08 — Structure & exit

How capital comes in, and how it comes out

  1. 01Parent company business curation & funding
  2. 02Creation of subsidiaries via business transfer
  3. 03Scale-up capital
    Present exercise
  4. 04Business expansion & value creation
  5. 05Institutional capital (FPO / QIP)
  6. 06Greater business scale-up, capital formation & acquisitions

Tap a step to see what happens at that stage.

ENTRY

CCPS in each subsidiary

Inward capital is issued as Cumulative Convertible Preference Shares (CCPS) in each subsidiary, convertible at the end of Year Five.

YEAR 5

Demerger & listing

Simultaneously, the subsidiary is listed by way of demerger from the listed parent, separately on BSE & NSE.

YEAR 6

FPO or QIP

An FPO (in case of Offer for Sale) or QIP (in case all funds go into the company) is planned.

We would be glad to receive long-term funds from marquee family offices and early-stage funds in these subsidiaries.

We are committed to delivering a greater RoI over the investment period and beyond.

Contact Manish Turakhia